Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORD-STAR: Active Conventional Therapy vs Biologics in Early RA
NCT01491815Phase 4Unknown
- Sponsor
- Karolinska Institutet
- Start
- Dec 2012
- Primary completion
- Jul 2023
- Modality
- Antibody Fragments, Polymer-based Nanoparticles, Antibody Conjugates
- Countries
- 6
01
Overview
A Phase 4 trial of certolizumab pegol, abatacept, tocilizumab in rheumatoid arthritis (RA), sponsored by Karolinska Institutet. Status: unknown.
02
Drugs
certolizumab pegolabatacepttocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01491815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491815.